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Temporal Lobe Impairment in West
Syndrome: Event-Related Potential
Evidence
Klaus Werner, MD, PhD,1,2,3 Tangunu Fosi, PhD, MRCPCH,1,2,3
Stewart G. Boyd, MD,2,3 Torsten Baldeweg, MD,4
Rod C. Scott, PhD, MRCPCH,1,3,5,6 and Brian G. Neville, FRCP1,3,5
Objective: This study investigates auditory processing in infants with West syndrome (WS) using event-related poten-
tials (ERPs).
Methods: ERPs were measured in 25 infants with mainly symptomatic WS (age range5 3–10 months) and 26 healthy
term infants (age range53–9 months) using an auditory novelty oddball paradigm. The ERP recordings were made
during wakefulness and repeated in stage II sleep.
Results: The obligatory components (P150, N250, P350) and novelty response components (P300, Nc) were recorda-
ble during both sleep and wakefulness in patients and controls. All ERP latencies decreased with age in controls but
not in the WS group (age 3 group interaction, F5 22.3, p<0.0001). These ERP latency alterations were not affected
by pharmacological treatment for WS.
Interpretation: This study demonstrated a persistently altered ERP signature in patients with a recent history of
infantile spasms. The prolongation of auditory obligatory and novelty ERPs in WS patients indicates a severe failure
of temporal lobe maturation during infancy. It remains to be investigated whether this predicts long-term cognitive
impairments characteristic for this epileptic encephalopathy.
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Epilepsies of childhood have a strikingly high inci-dence of behavioral, psychiatric and cognitive disor-
ders.1–4 West syndrome (WS), which affects about 1 in 3,000
live births, is the commonest severe epilepsy syndrome.5,6 It
presents at 4 to 6 months of age with epileptic spasms (infan-
tile spasms [IS]), characteristic electroencephalographic
(EEG) changes, and psychomotor regression.7 The two-fifths
of children with WS who have lesions8 are more likely
to experience seizure intractability9 and marked cognitive
and social impairment.10 The epilepsy in this subgroup of
symptomatic WS patients is a significant determinant of
outcome.
Prospective studies of children with perinatal brain
injury and with tuberous sclerosis found that those who
developed WS regressed in visual and cognitive abilities.11,12
These observations are consistent with epileptiform activity
impairing long-term cognitive and neurological function
beyond that observed from the underlying brain lesions
alone. The pathophysiological basis of the term epileptic
encephalopathy13–15 remains unclear, however. Preliminary
evidence would suggest dynamic effects of epilepsy on the
connection architecture of the developing brain bilaterally.
First, prompt removal of focal epileptogenic lesions, which
controls seizures, can normalize contralateral EEG abnor-
malities16 and promote development.17–20 Second, a pro-
longed schedule of anticonvulsant weaning is typically
required following successful lesion excision to maintain
seizure freedom.20 This led us to hypothesize that
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epileptogenesis interferes with the normal remodeling of the
connection architecture of the developing brain bilaterally.
Mid-infancy, the peak onset of WS, is a critical
period for temporal lobe development.17,21–25 We there-
fore reasoned that the effects of WS on the infant brain
will be prominent for temporal lobe function. Here we
used auditory event-related potentials (ERPs) to measure
temporal lobe function with a time resolution in the order
of milliseconds.26 Specifically, obligatory ERP responses to
simple tone stimuli allow us to make inferences on the
maturation of the auditory cortex,27,28 whereas ERPs to
rare environmental sounds elicit prominent novelty ERPs
in temporal, frontal, and parietal association cortex.29 ERP
data were utilized to evaluate differences in temporal lobe
maturation between symptomatic WS patients and healthy
control infants during the first year of life.
Subjects and Methods
Subjects
The study was approved by the ethics committee of the Univer-
sity College London Institute of Child Health and Great
Ormond Street Hospital, London (GOSH). Parental informed
consent was obtained prior to participation as a control or as a
patient. Neonatal hearing tests were all normal.
Controls
Controls were recruited from the community and university
staff. All showed age-appropriate development and no congeni-
tal hearing impairment, chronic otitis media, or other signifi-
cant health problems as obtained by parental interview. They
also had a normal neurological and structured developmental
examination that screened for fine motor, vision, gross motor,
hearing and speech, and social behavior impairments.30 Formal
psychometric testing was not performed.
Patients
Cases were recruited prospectively and consecutively over 4 years
(2002–2006) from GOSH. The entry criteria were a diagnosis of
WS based on clinical and EEG features and informed parental
consent. The study did not interfere with patients’ normal clinical
management. Clinical investigations were brain neuroimaging
(predominantly magnetic resonance imaging [MRI]) and neuro-
metabolic investigation of blood, urine, and cerebrospinal fluid.
The brain MRI scan was inspected and reported by neuroradiolo-
gists at GOSH. For statistical analysis, scans were classified as
either normal or not normal. Treatment was initiated after video-
EEG confirmation of a diagnosis of WS. Parents were counseled
on WS by their neurologist, and received information regarding
the first-line therapies for infantile spasms. The therapeutic agent
was agreed between neurologist and parents.
Experiments
The study intervention was a pseudorandomized oddball auditory
stimulus paradigm comprising a 1,000Hz sinusoidal pure tone
standard stimulus (80%), a 2,000Hz “deviant” (10%), and novel
environmental sounds (10%). The latter consisted of musical
instruments, animal calls, machine sounds, and white noise sounds.
Each stimulus lasted 200 milliseconds, including 10-millisecond
rise and fall times. Stimulus onset asynchrony was 700 millisec-
onds. The paradigm is described in more detail elsewhere.31
Data Acquisition
Scalp EEG was recorded in an electrically shielded sound-
attenuated chamber using Ag/AgCl electrodes in the interna-
tional 10/20 montage. Gentle scalp abrasion with commercial
gel minimized impedance to <10 kX, and adhesive paste
affixed the electrodes. An electrode at the right external canthus
and another in the left infraorbital area detected horizontal and
vertical eye movement artifacts.
The experiments occurred around midday, with the
infant on its mother’s knee, having just been fed. An experi-
ment during wakefulness was followed by a repeat during natu-
ral sleep. Two blocks of the same auditory paradigm were
presented in each state, with different novelty sounds in each.
Computer software (Presentation; Neurobehavioral Systems,
Albany, NY) delivered auditory stimuli to the infant via speak-
ers located 30cm from each ear. Sound intensity was adjusted
to be comfortable for infants (about 60dB SPL).
EEG data were acquired in continuous mode with a
Neuroscan recording system (Neuroscan, El Paso, TX). The
EEG signal was digitized at a sampling of 500Hz, amplified
(band pass5 0.15–100Hz), and stored at 32-bit resolution for
offline analysis. The data were analyzed without additional
offline filtering. The abnormality of the background EEG dur-
ing the ERP recording session in stage II non–rapid eye move-
ment (NREM) sleep was classified as either moderate, severe,
or hypsarrhythmic. Moderate abnormality showed excess slow
activity of similar amplitude to the ongoing activity, present
for <50% of the recording, with definite evidence of age–
appropriate activity. Severe abnormality was established by
continuous excess of slow activity and/or absence of age-
appropriate rhythmic activity and frequent epileptiform fea-
tures. Hypsarrhythmia was defined as the presence of diffuse,
high-amplitude, nonsynchronous slow-wave theta and delta
activity with loss of normal background features, with the pat-
tern being continuous when awake and fragmented in sleep.
Asymmetry in the hypsarrhythmic pattern was permitted in
the presence of structural lesions.
Data Processing
Data analysis was performed offline using Neuroscan Edit soft-
ware. Preprocessing was performed offline to reject artifacts and
to extract ERPs. Epochs exceeding 6300 mV in stage II sleep
were automatically rejected. EEG segments contaminated by
physical (eye blinks, eye movement, head movement, sucking,
or excessive muscle activity) and electronic artifacts were
rejected by visual assessment. Stage II NREM sleep as defined
by the following EEG criteria: the presence of sleep spindles,
K-complexes, and high-amplitude slow delta activity.32–36 The
arithmetic average locked to the epoch 2100 to 1800 millisec-
onds with respect to the presentation of each stimulus
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(standards, deviants, and novels) was computed to yield the
respective ERP responses. The ERP components were isolated
by referencing the data from the recording electrodes offline to
the average potential of the mastoid (M1 and M2) electrodes.37
Following this demonstration of ERP components, the average
all scalp electrodes was used as the reference for performing
amplitude and latency measurements.
The ERPs for each block were extracted from the
responses to standards, deviants, and novels. The data for the
second block of experiments were inspected visually to establish
replication of the components identified in the first block. A
participant had valid data if the specific component was clearly
visible across multiple neighboring electrodes and was demon-
strated in both experiment blocks of the 2 arousal states. The
statistical analysis described below was performed on the ERP
components isolated in the first block of experiments for partic-
ipants with valid data.
ERPs
SIGNAL-TO-NOISE RATIO AND STIMULUS SET SIZE. The
study design incorporated a minimum number of stimulus
repetitions required to identify the novelty ERP robustly.
This was based on typical ERP amplitudes reported in sleep-
ing infants, and the estimated mean EEG background ampli-
tude in stage II sleep. A novelty ERP signal of amplitude
615 mV and a mean background amplitude of 675 mV
results in a signal-to-noise ratio (SNR) of 0.2. Due to SNR
scaling as a function of the square-root of the number of
stimuli, we required a minimum of 100 novelty stimulus rep-
etitions to achieve an SNR of 2.38 The basic stimulus block
comprised 1,050 stimuli (100 novel stimuli, 100 deviants,
and 850 standards). Evaluation of the performance of the
paradigm revealed that technically satisfactory obligatory and
novelty responses could be measured distinctly from the
background.
ERP MEASUREMENT. The component peak amplitude and
latency were measured manually from the prestimulus baseline
The obligatory ERP response (also known as the N1-T-com-
plex), produced by repetition of the standard,28 occurs over the
temporal regions after 100 to 300 milliseconds in children.39
The components of the obligatory response were recognized:
P150, N250, and P350. The mismatch negativity (MMN) was
defined as the largest negative deflection exceeding the average
baseline voltage by 1.0mV at 80 to 300 milliseconds after stimu-
lus onset in the difference between the response to the deviant
stimuli and the standards immediately preceding. This had to
be present at any 2 of the 4 electrodes F3, F4, C3, and C4.
The novelty response is maximal at the frontocentral electro-
des.40–43 We measured the novelty P300, which was the largest
positive deflection between 200 and 450 milliseconds, and the
Nc response (sometimes termed N450), a negative slow wave
occurring immediately after the novelty P3 at 400 to 700 milli-
seconds poststimulus. The novelty P300 was measured at M1,
M2, P7, P8, C3, C4, and Cz electrodes; the novelty Nc at F3,
F4, F7, F8, and Fz electrodes.
Statistical Analysis
Statistical analyses were performed using SPSS v16 (SPSS, Chi-
cago, IL) package. Repeated measures analysis of variance was
used to compare the amplitudes and latencies of WS patients
with control subjects. This utilized the measurements over the
electrodes that showed the largest amplitude of the waveform.
These were C3, C4, F3, and F4 for each obligatory component;
M1 and M2 for the novelty P300; and Fz and Cz for the nov-
elty Nc. Fisher exact chi-square test (1-tailed) was used post
hoc to verify whether a better yield of ERP components
occurred with less severe background EEG abnormality. The
existence of a relationship between ERP components and clini-
cal factors was tested using logistic regression. The clinical fac-
tors tested were: development before seizure onset (normal,
abnormal), brain MRI abnormality (present, absent), EEG
background abnormality (moderate, severe), and focal epilepti-
form activity (present, absent). The criterion for statistical evi-
dence was p< 0.05.
Results
Demographics
The 25 WS patients (10 female, 15 male,) had a median
age of onset of infantile spasms of 4 months old
(range5 3–9 months). The age distribution at onset of
infantile spasms was 3 to 4 months (n5 13), 5 to 8 months
(n5 10), and 9 months (n5 2). Their ERP testing was
performed at a median age of 8 months (range5 3–10
months). The median lag to ERP testing from the onset of
infantile spasms was 3 months (range5 2 weeks to 13
months). There was no difference in patient demographic
characteristics by sex. None of the patients showed normal
developmental ability on clinical assessment.
The 26 controls (13 female, 13 male) who were
recruited to the ERP study had a median age at ERP
recording of 7 months (range5 3–9 months). The break-
down of ages at ERP recording (controls, patients) was:
3 to 4 months (n5 5, n5 5), 5 to 8 months (n5 10,
n5 9), and 9 months (n5 11, n5 11). There was no
statistical difference in the demographic characteristics of
the control and patient groups at the time of ERP
recording.
Drug Treatment
FOR INFANTILE SPASMS. Treatment for infantile
spasms was initiated at a median lag of 4 weeks
(range5 2–20 weeks). Seventeen patients were treated
with steroids. Fifteen were treated with vigabatrin, of
whom 7 did not subsequently receive steroids. Of the 6
patients who had experienced no further IS following the
initiation of treatment, control had been achieved on the
first agent in 4 cases (3 steroids, 1 vigabatrin). The cessa-
tion of spasms occurred within 2 weeks of initial
treatment.
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FOR OTHER SEIZURES. Ten patients were treated for
other seizures prior to referral to our center.
EEG
The EEG recording was possible in 23 patients during both
wakefulness and sleep, whereas in 1 patient it was only pos-
sible during wakefulness and in another patient only during
sleep. The EEG background was severely abnormal in 12
patients during wakefulness (including hypsarrhythmia in
1), and in 16 patients during sleep (including hypsarrhyth-
mia in 4). Focal discharges over temporal leads or multifocal
discharges involving the temporal lobe were present in 15
patients (EEG details available upon request).
MRI
The brain MRI scans were classified into 5 groups: nor-
mal (n5 8), malformations of cortical development
(n5 8), tuberous sclerosis (n5 3), hypoxic–ischemic
changes (n5 3), or delayed myelination without cortical
abnormality (n5 3; Table 1).
ERP Components
IDENTIFICATION OF OBLIGATORY COMPO-
NENTS. The presence of clearly defined ERP compo-
nents (Fig 1) was used as a measure of normal auditory
cortex maturation.28,37 Patients were more likely than con-
trols to fail to show the full triadic obligatory response
component structure (p< 0.001 for all components:
P150, N250, P350) for each arousal state (Table 2).
MMN. The MMN was evaluated as part of this study,
using the 2,000Hz deviant stimulus presented at a 10%
probability. This large frequency deviance was expected
to elicit an MMN on the basis of previous work in
infants.44 However, the criterion for reliability of an ERP
component in this study (demonstrability in both blocks
of both states) was not fulfilled for the MMN in any
patient and was met by only 2 control subjects.
NOVELTY COMPONENTS. The novelty components
were detected in both blocks during sleep in most con-
trol subjects (96%, 25 of 26) and in a proportion of WS
infants (60%, 15 of 25). During wakefulness, novelty
ERPs were present in both blocks in 88% (23 of 26) of
control subjects and in 44% (11 of 25) of WS patients.
ERP Components and the EEG Background
All controls had normal EEGs. Patients showed a graded
relationship between the severity of the abnormality of
the EEG background and the presence of obligatory and
novelty ERP components for both sleep and wakefulness.
Considering the obligatory and novelty responses, full
ERP component structure manifested less with severe as
compared to moderate background EEG abnormality in
both states. (Fisher exact test, p5 0.004). This reflects
the following details: the proportion of patients with
severe background EEG abnormality compared to mod-
erate background EEG abnormality showing all obliga-
tory ERP components was 4 of 16 versus 7 of 8 during
sleep (Fisher exact test, p5 0.025) and 2 of 12 versus 9
of 10 during wakefulness (p5 0.001) . The proportion
showing all novelty ERP components was 9 of 16 versus
8 of 8 during sleep (p5 0.033) and 4 of 12 versus 8 of
10 during wakefulness (p5 0.038).
Group Comparisons
OBLIGATORY COMPONENTS. The obligatory ERP
response (P150, N250, P350) showed an age-dependent
shortening of the latency of all components in controls
(see Fig 1), which was not seen in patients (Table 3).
The obligatory response latencies were prolonged in WS
compared to controls during both wakefulness and sleep
(Fig 2, Table 4).
NOVELTY COMPONENTS. The novelty ERP response
(P300, Nc) showed an age-dependent shortening of the
latency in healthy infants (Fig 3). This was statistically
significant for the novelty P300 (see Table 3). The group
comparison of novelty ERPs (Fig 4) evidenced a latency
prolongation in WS patients (sleep and wake data col-
lapsed: F5 6.74, p5 0.012 for P300 latency; F5 4.76,
p5 0.037 for Nc latency). The data are shown separately
for each arousal state in Table 4.
The obligatory and novelty ERP latencies shortened
with age in controls but not WS patients (for sleep and
wake data collapsed: age 3 group interaction, F5 22.3,
p< 0.0001). ERP amplitudes did not show group differ-
ences, with 1 exception. There was a trend toward a
larger Nc amplitude in WS patients (F5 3.97, p5 0.05
for sleep and wake data collapsed).
MMN. The majority of study subjects did not fulfil the
criterion for a reliable MMN, precluding group statistical
comparison between controls and patients.
Relationship between Demographic and Clinical
Factors
Logistic regression failed to find a relationship between
age, gender, or clinical factors and the presence of ERP
components in WS patients.
Unilateral Epileptogenic Lesions, Bilateral
Effects
The observation was made of 2 cases of unilateral right-
sided lesions that involved the temporoparietal junction,
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in which the contralateral auditory novelty ERP response
was abolished (data available upon request). In contrast,
unilateral lesions in other regions did not abolish the
contralateral novelty response.
Discussion
This study probed alterations of temporal lobe function
in patients with a history of WS using auditory ERPs to
frequent sounds (obligatory ERPs) and rare novel sounds
(novelty ERPs). The obligatory ERP responses (P150,
N250, P350) are presumed to be generated within audi-
tory cortex, whereas temporoparietal and frontal associa-
tion cortex are the sources of the novelty responses
(P300, Nc).29 These ERP signatures of basic (acoustic)
and higher order (novelty) auditory processing were
detectable in all healthy control infants and in a smaller
proportion of WS patients. Notably, patients’ ERPs failed
to show the full complement of age-appropriate compo-
nents and had prolonged peak latencies. A limitation of
this study is that MMN, which is generated in the supe-
rior temporal plane in response to deviant sounds,45
could not be elicited reliably.
To our knowledge, this is the first study demon-
strating robust ERP latency prolongation in patients with
WS. This appears to be due to the failure of ERP com-
ponents in WS patients to show the expected rapid age-
dependent latency reduction during the first 2 years of
life.27,46 The findings in WS are in keeping with the
observation of prolonged ERP latencies in heterogeneous
groups of children with other severe epilepsies.47–49 The
finding in WS of ERP impairment across the hierarchy
of auditory processing could potentially underlie the lan-
guage deficits recognized in these patients.50
We cannot rule out the possibility that anti-epilepsy
drug (AED) treatment influenced ERP latencies in the
absence of pretreatment ERP recordings. As patients had
been treated for WS, it is inferred that treatment did not
normalize auditory ERPs. Nevertheless, we failed to find
ERP differences between WS patients on AED treatment
and those without, as well as between those treated with
steroids compared to vigabatrin. There are no published
data on the effect on ERPs of typical treatment doses of
the anticonvulsants used for WS. There is, however,
some limited evidence to suggest that the findings in the
present study are probably not primarily treatment-
induced. First, steroid treatment (using adrenocorticotro-
pic hormone and corticotropin-releasing hormone at low
dose) did not alter ERP latencies in healthy adult con-
trols.51,52 Second, in other severe epilepsies therapeutic
doses of other anticonvulsants did not alter ERP laten-
cies.47,53 We did not identify clear ERP differences in
relation to clinical factors such as development beforeT
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seizure onset, the presence of brain MRI abnormality,
EEG background abnormality, and focal epileptiform
activity, albeit limited by small sample size.
The ERP data are consistent with a qualitative dif-
ference in temporal lobe maturation between the WS
group and controls. The former showed less integrity of
ERP component structure, with a lower probability for
generating all obligatory components, and did not show
evidence of the marked age-related latency reduction
found in control infants. The integrity of ERP compo-
nent structure was poorer, with more severe EEG back-
ground abnormality and fewer ERP components being
isolated. The higher amplitude of the background EEG
was not, however, a sufficient explanation for WS
patients’ ERP findings. First, if their background EEG
merely rendered ERPs less identifiable, then patients’
ERP amplitude ought to be diminished. However, the
ERP amplitude did not differ between patients and con-
trols. Second, the novelty ERPs’ detectability would be
expected to deteriorate during sleep given the more
abnormal and higher amplitude background EEG during
sleep in WS patients. This was found not to be the case.
For these reasons, we do not assume that the ERP find-
ings in WS simply represent the consequence of reduced
signal-to-noise ratio given the high-amplitude back-
ground EEG in this group.
The inference that the developmental patterning of
the temporal lobe connections differs between controls
and patients is supported by our ERP findings in cases
of right hemispheric lesion. Our observation of bilateral
FIGURE 1: The obligatory event-related potential morphology in 3 age groups of healthy control infants during wakefulness
and sleep at frontal electrodes F3 and F4. Note shortening of P150 latency with emergence of N250 and P350 with increasing
age.
TABLE 2. Identification of Obligatory ERP
Components
ERP Component Awake Asleep
P150
Controls 26/26 (100%) 26/26 (100%)
Patients 12/25 (48%) 12/25 (48%)
p, chi-square test <0.0001 <0.0001
N250
Controls 22/26 (84%) 20/26 (77%)
Patients 8/25 (32%) 5/25 (25%)
p, chi-square test <0.001 <0.0001
P350
Controls 22/26 (84%) 20/26 (77%)
Patients 8/25 (32%) 6/25 (23%)
p, chi-square test <0.001 <0.001
In each arousal state, patients were less likely than controls
to show all 3 components.
ERP5event-related potential.
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ERP alteration in cases with unilateral epileptogenic
structural lesions of the right temporal lobe hints at a
degree of interhemispheric dependence of brain func-
tional maturation. The suggestion of earlier maturation
of the right cerebral hemisphere in infancy54 could mean
that it reaches its peak density of synaptic connections
TABLE 3. Shortening of ERP Latencies during Sleep with Age
ERP Component Patients Controls
n R p n R p
Obligatory
P150 12 26
Right (F4) 0.382 0.05 20.473 <0.0001
Left (F3) 0.379 0.06 20.519 <0.0001
N250 5 20
Right (F4) 20.330 0.25 20.525 <0.0001
Left (F3) 20.280 0.33 20.506 <0.0001
P350 6 20
Right (F4) 20.180 0.52 20.546 <0.0001
Left (F3) 20.189 0.50 20.512 <0.0001
Novelty
P300 15 25
Right (M2) 20.255 0.15 20.529 <0.0001
Left (M1) 20.058 0.75 20.432 0.001
Nc 15 0.010 0.96 25 20.467 0.002
The Pearson correlation coefficient (R) between ERP latency and age (in days) is shown. Controls showed a shortening of all ERP
latencies with age, which was not reproduced in the West syndrome group.
ERP5event-related potential.
FIGURE 2: Group mean obligatory event-related potentials at electrode F3 in sleep for controls and patients.
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TABLE 4. ERP Group Statistics for Controls and Patients with West Syndrome
ERP Component West Syndrome,
Mean6 SD Controls, Mean6 SD p
Sleep Awake Sleep Awake Sleep Awake
Obligate responsea
P150 latency 394 (87) 298 (95) 262 (44) 207 (38) <0.001b <0.001b
P150 amplitude 11.0 (7.7) 4.4 (13) 7.8 (5.4) 4.7 (2.0) 0.183 0.218
N250 latency 321 (95) 363 (118) 267 (33) 284 (47) 0.008b <0.001b
N250 amplitude 221.4 (16.6) 216.8 (6.5) 222.0 (7.3) 218.1 (8.5) 0.689 0.299
P350 latency 616 (219) 513 (160) 462 (60) 386 (52) 0.017b 0.018b
P350 amplitude 5.9 (4.0) 3.2 (2.7) 5.3 (3.1) 3.2 (2.9) 0.608 0.429
Novelty responsec
Novelty P300 latency 692 (152) 950 (193) 585 (91) 729 (74) <0.001b <0.001b
Novelty P300 amplitude 19.6 (18.7) 7.7 (3.6) 14.2 (5.6) 6.5 (4.1) 0.378 0.343
Novelty Nc latency 772 (233) 837 (130) 665 (102) 791 (76) 0.280 0.037b
Novelty Nc amplitude 213.4 (12.6) 24.8 (3.6) 29.5 (7.6) 23.8 (4.7) 0.015b 0.453
The analysis is based on those subjects showing the particular component. Latencies are in milliseconds and amplitudes are in
microvolts.
aFor obligatory response, see Table 2.
bSignificant difference.
cFor the novelty response, the number of subjects for patients and controls was 25 and 15 respectively in sleep and 23 and 11
respectively awake, for both the novelty P300 and novelty Nc.
ERP5event-related potential; SD5 standard deviation.
FIGURE 3: Novelty event-related potential responses in 3 age groups of healthy control infants during sleep. Note inversion of
P300 and Nc over temporal leads (labeled on the left side).
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first. We presume that such connections might facilitate
a functional effect at a distance or diaschisis upon the
maturation of cortical networks in the contralateral
hemisphere to account for our observations with right
temporal lobe lesions. The diaschisis phenomenon has
been proposed to account for the finding that focal
cortical resection around the epileptogenic lesion, or
hemispheric disconnection, can restore the contralateral
hemisphere’s functional and hemodynamic matura-
tion.16,55–57 It will be important to determine whether
impairments in interhemispheric temporal lobe connec-
tivity impact on the development of verbal skills, as has
been reported for cohorts of children with perinatal
pathology.58,59
In conclusion, an impairment of temporal lobe mat-
uration is a likely sequela of WS. This is proposed to reflect
defective neuroplasticity associated with WS. Further study
should establish the predictive value of ERP findings for
cognitive and language development in affected children.
New treatments that specifically modulate neuroplasticity
promise improved future outcomes in WS,60 and the use
of auditory ERPs may permit monitoring of temporal lobe
maturation following such treatments.
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